Analysis of the Phenotype Differences in Siblings with Alkaptonuria

Area of Science:

• Genetics
• Metabolic Disorders
• Biochemistry

Background:

• Alkaptonuria (AKU) is a rare autosomal recessive metabolic disorder.
• It results from mutations in the homogentisate 1,2-dioxygenase (HGD) gene, leading to homogentisic acid (HGA) accumulation.
• HGA accumulation causes ochronosis and severe ochronotic spondylo-arthropathy.

Purpose of the Study:

• To investigate phenotypical variability in Alkaptonuria (AKU) patients with identical HGD genetic variants.
• To analyze baseline clinical data from AKU sibling pairs/groups within the SONIA 2 study.

Main Methods:

• Systematic analysis of baseline clinical data from 24 AKU sibling pairs/groups.
• Evaluation of phenotypical differences among patients sharing the same HGD genetic variants.

Main Results:

• Significant variability in disease severity was observed, even among siblings with the same HGD genetic variants.
• Previous studies indicated no significant differences in HGA levels or clinical symptoms based on residual HGD activity (1% vs >30%).
• Smaller variance in HGA excretion was previously noted within sibling pairs sharing a common genotype.

Conclusions:

• Genetic factors alone do not fully explain the phenotypic variability in Alkaptonuria (AKU).
• Unidentified genetic, biomechanical, or environmental factors likely contribute to the diverse disease severity and progression in AKU patients.
• Further research is needed to elucidate these additional modifying factors influencing AKU pathogenesis.